£1 billion for UK cancer research centre
Aviva Capital Partners (ACP) and developer Socius have unveiled plans for a new £1 ($1.3) billion development to create a leading centre for cancer research in Sutton, London, UK.
The development will be delivered on a 12-acre site at the London Cancer Hub, adjacent to The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust’s Sutton site.
According to an analysis by London Borough of Sutton, by the time the development is complete, the London Cancer Hub will support 13,000 jobs in total and contribute an estimated £1.2 billion per year to the UK economy.
The new buildings will range from large-scale facilities for global pharmaceutical and life sciences companies through to smaller, flexible lab and incubator spaces for start-ups, with the capacity to accommodate wet labs, Good Manufacturing Practice facilities, specialist equipment as well as modern office and collaborative workspaces.
The development will also deliver restaurants and cafes, a creche and homes for approximately 220 key workers. It will also include a ‘Learning Lab’, comprising classroom and educational spaces.
Professor Kristian Helin, Chief Executive of The Institute of Cancer Research, London, said: “We’re very pleased to be working with Aviva Capital Partners and Socius on plans to further build the thriving multidisciplinary research district in Sutton, and we’re hoping that the project will attract a range of companies to locate here alongside us, as well as provide a home for companies that spin out from our science in the future.
“The London Cancer Hub has great potential to enhance our scientific partnerships with companies in the pharmaceutical and broader life-sciences industries, in areas from the discovery and development of new cancer drugs to the creation of new treatment and diagnostic technologies.”
Diana Spencer, Senior Digital Content Editor, DDW
